Gamma-interferon in aplastic anemia: inability to detect significant levels in sera or demonstrate hematopoietic suppressing activity
暂无分享,去创建一个
[1] R. Shadduck,et al. Interferon‐induced aplasia: Evidence for t‐cell‐mediated suppression of hematopoiesis and recovery after treatment with horse antihuman thymocyte globulin , 1985, American journal of hematology.
[2] R. Storb,et al. Subsets of patients with aplastic anemia identified by flow microfluorometry. , 1985, The New England journal of medicine.
[3] G. Trinchieri,et al. Immune interferon: a pleiotropic lymphokine with multiple effects. , 1985, Immunology today.
[4] N. Young,et al. Circulating activated suppressor T lymphocytes in aplastic anemia. , 1985, The New England journal of medicine.
[5] N. Young,et al. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[6] G. Trinchieri,et al. Response of resting human peripheral blood natural killer cells to interleukin 2 , 1984, The Journal of experimental medicine.
[7] J. Vilček,et al. Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[8] N. Young,et al. Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro. , 1984, Journal of immunology.
[9] R. Storb,et al. Acquired severe aplastic anemia: progress and perplexity. , 1984, Blood.
[10] J. Vilček,et al. Natural and recombinant Escherichia coli-derived interferon-gamma differ in their reactivity with monoclonal antibody. , 1984, Journal of immunology.
[11] B. Aggarwal,et al. Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin , 1984, The Journal of experimental medicine.
[12] B. Torok-Storb,et al. Correlation of two in vitro tests with clinical response to immunosuppressive therapy in 54 patients with severe aplastic anemia. , 1984, Blood.
[13] S. Matis,et al. Natural killer cells suppress human erythroid stem cell proliferation in vitro. , 1984, Blood.
[14] R. Storb,et al. Therapy of severe aplastic anemia with anti-human thymocyte globulin and androgens: the effect of HLA-haploidentical marrow infusion. , 1984, Blood.
[15] T. Yokochi,et al. Human B Cell and B Cell Blast-Associated Surface Molecules Defined with Monoclonal Antibodies , 1984 .
[16] E. Gluckman,et al. Immunosuppressive treatment of aplastic anemia as an alternative treatment for bone marrow transplantation. , 1984, Seminars in hematology.
[17] R. Neerhout,et al. T-lymphocyte--mediated granulopoietic failure. In vitro identification of prednisone-responsive patients. , 1983, The New England journal of medicine.
[18] G. Hale,et al. Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement. , 1983, Blood.
[19] R. Storb,et al. Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia. , 1983, Blood.
[20] L. Juliano,et al. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. , 1983, Journal of immunology.
[21] D. Weigent,et al. Recombinant gamma interferon enhances natural killer cell activity similar to natural gamma interferon. , 1983, Biochemical and biophysical research communications.
[22] J. Phillips,et al. NKP-15: a monoclonal antibody reactive against purified human natural killer cells and granulocytes. , 1983, Immunology letters.
[23] R. Champlin,et al. Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. , 1983, The New England journal of medicine.
[24] G. Chikkappa,et al. T gamma (T gamma) cells suppress growth of erythroid colony-forming units in vitro in the pure red cell aplasia of B-cell chronic lymphocytic leukemia. , 1982, The Journal of clinical investigation.
[25] Neumann Ha,et al. Effect of interferon on pluripotent hemopoietic progenitors (CFU-GEMM) derived from human bone marrow. , 1982 .
[26] B. Askonas,et al. Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell , 1982, Nature.
[27] C. Balch,et al. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). , 1981, Journal of immunology.
[28] A. Gratwohl,et al. Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation. , 1981, British medical journal.
[29] B. Rabin,et al. Aplastic anemia following infectious mononucleosis: possible immune etiology. , 1979, Experimental hematology.
[30] T. Merigan,et al. Suppressive effect of interferon on erythroid cell proliferation. , 1979, Experimental hematology.
[31] A. Bacigalupo,et al. Bolus methylprednisolone in severe aplastic anemia. , 1979, The New England journal of medicine.
[32] J. Gutterman,et al. Human leukocyte interferon preparation blocks granulopoietic differentiation. , 1979, Blood.
[33] N. Abdou,et al. Aplastic anemia associated with bone marrow suppressor T‐Cell hyperactivity: Successful treatment with antithymocyte globulin , 1978, American journal of hematology.
[34] J. Finke,et al. Case report. Aplastic anemia. Effect of antithymocyte globulin on erythroid colony formation. , 1978, Cleveland Clinic quarterly.
[35] R. Good,et al. Aplastic anaemia: Evidence for an immunological mechanism. , 1976, Lancet.
[36] J. Youngner,et al. Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity. , 1973, Journal of immunology.